[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB2272217B - Anti-cancer cyclopentaquinazoline tricyclic derivatives - Google Patents

Anti-cancer cyclopentaquinazoline tricyclic derivatives

Info

Publication number
GB2272217B
GB2272217B GB9320769A GB9320769A GB2272217B GB 2272217 B GB2272217 B GB 2272217B GB 9320769 A GB9320769 A GB 9320769A GB 9320769 A GB9320769 A GB 9320769A GB 2272217 B GB2272217 B GB 2272217B
Authority
GB
United Kingdom
Prior art keywords
cyclopentaquinazoline
cancer
tricyclic derivatives
tricyclic
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB9320769A
Other versions
GB9320769D0 (en
GB2272217A (en
Inventor
Francis Thomas Boyle
James William Crook
Zbigniew Stanley Matusiak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Syngenta Ltd
Original Assignee
Zeneca Ltd
British Technology Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929223352A external-priority patent/GB9223352D0/en
Application filed by Zeneca Ltd, British Technology Group Ltd filed Critical Zeneca Ltd
Priority to GB9320769A priority Critical patent/GB2272217B/en
Publication of GB9320769D0 publication Critical patent/GB9320769D0/en
Publication of GB2272217A publication Critical patent/GB2272217A/en
Application granted granted Critical
Publication of GB2272217B publication Critical patent/GB2272217B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9320769A 1992-11-06 1993-10-08 Anti-cancer cyclopentaquinazoline tricyclic derivatives Expired - Lifetime GB2272217B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9320769A GB2272217B (en) 1992-11-06 1993-10-08 Anti-cancer cyclopentaquinazoline tricyclic derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929223352A GB9223352D0 (en) 1992-11-06 1992-11-06 Tricyclic compounds
GB9320769A GB2272217B (en) 1992-11-06 1993-10-08 Anti-cancer cyclopentaquinazoline tricyclic derivatives

Publications (3)

Publication Number Publication Date
GB9320769D0 GB9320769D0 (en) 1993-12-01
GB2272217A GB2272217A (en) 1994-05-11
GB2272217B true GB2272217B (en) 1996-07-31

Family

ID=26301928

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9320769A Expired - Lifetime GB2272217B (en) 1992-11-06 1993-10-08 Anti-cancer cyclopentaquinazoline tricyclic derivatives

Country Status (1)

Country Link
GB (1) GB2272217B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
CA2804889A1 (en) * 2010-07-19 2012-01-26 Onyx Pharmaceuticals, Inc. Synthesis of cyclopentaquinazolines

Also Published As

Publication number Publication date
GB9320769D0 (en) 1993-12-01
GB2272217A (en) 1994-05-11

Similar Documents

Publication Publication Date Title
AU4025789A (en) Tricyclic benzodiazepine derivatives
GB2265148B (en) Anti-cancer compounds
GB2253849B (en) Anti-cancer compounds
HU9300488D0 (en) Tricyclic benzodiazepine derivatives
ZA939291B (en) Diazepine derivatives
ZA916427B (en) Tricyclic pyridone derivatives
LTIP657A (en) Benzodiazepine derivatives
ZA947314B (en) Tricyclic derivatives
GB9410907D0 (en) Anti-cancer compounds
GB2272217B (en) Anti-cancer cyclopentaquinazoline tricyclic derivatives
GB9212095D0 (en) Polycyclic dyes
HU9500007D0 (en) Tricyclic cepheme derivatives
GB9212411D0 (en) Polycyclic dyes
GB9303015D0 (en) Polycyclic dyes
GB9207958D0 (en) Anti-cancer compounds
GB9021855D0 (en) Tricyclic derivatives
GB9201913D0 (en) Anti-cancer compounds
GB9205908D0 (en) Anti-cancer compounds
GB9218051D0 (en) Anti-cancer compounds
IE881764L (en) Tricyclic pryidone derivatives
IE891980L (en) Tricyclic 3-oxo-propanenitrile derivatives
GB9223370D0 (en) Tricyclic compounds
GB9213511D0 (en) Tricyclic cefem sulphones
GB9107837D0 (en) Anti-cancer compounds
GB9107845D0 (en) Anti-cancer compounds

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Expiry date: 20131007